JP2003259891A - Method for producing dehydroabietic acid derivative - Google Patents

Method for producing dehydroabietic acid derivative

Info

Publication number
JP2003259891A
JP2003259891A JP2002061259A JP2002061259A JP2003259891A JP 2003259891 A JP2003259891 A JP 2003259891A JP 2002061259 A JP2002061259 A JP 2002061259A JP 2002061259 A JP2002061259 A JP 2002061259A JP 2003259891 A JP2003259891 A JP 2003259891A
Authority
JP
Japan
Prior art keywords
acid
dehydroabietic acid
dehydroabietic
producing
acid derivative
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2002061259A
Other languages
Japanese (ja)
Inventor
Hiroshi Sakamaki
弘 酒巻
Susumu Kitanaka
進 北中
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nihon University
Original Assignee
Nihon University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nihon University filed Critical Nihon University
Priority to JP2002061259A priority Critical patent/JP2003259891A/en
Publication of JP2003259891A publication Critical patent/JP2003259891A/en
Pending legal-status Critical Current

Links

Landscapes

  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

<P>PROBLEM TO BE SOLVED: To provide a dehydroabietic acid derivative having a high added value from dehydroabietic acid. <P>SOLUTION: This method for producing the dehydroabietic acid derivative is characterized by producing at least one dehydroabietic acid derivative selected from the group consisting of 7-oxodehydroabietic acid, 7-hydrodehydroabietic acid, and 15-hydroxy-7-oxodehydroabietic acid from dehydroabietic acid with plant cultured cells, Caragana chamlagu cultured cells. <P>COPYRIGHT: (C)2003,JPO

Description

【発明の詳細な説明】Detailed Description of the Invention

【0001】[0001]

【発明の属する技術分野】本発明は、デヒドロアビエチ
ン酸誘導体の製造方法に関する。本発明はさらに詳細に
は、植物培養細胞を用いてデヒドロアビエチン酸からデ
ヒドロアビエチン酸誘導体を製造することからなる、デ
ヒドロアビエチン酸誘導体の製造方法に関する。
TECHNICAL FIELD The present invention relates to a method for producing a dehydroabietic acid derivative. The present invention more specifically relates to a method for producing a dehydroabietic acid derivative, which comprises producing a dehydroabietic acid derivative from dehydroabietic acid using plant cultured cells.

【0002】[0002]

【従来の技術】デヒドロアビエチン酸は、天然の松脂か
ら多量に得られる。そしてデヒドロアビエチン酸は、製
紙用サイジング剤等として工業的に有用な物質である
が、構造が確立されていてさらに付加価値の高い医薬品
等への変換が期待される。すなわち、デヒドロアビエチ
ン酸から得られる7−オキソデヒドロアビエチン酸、7
−ヒドロキシデヒドロアビエチン酸及び15−ヒドロキ
シ−7−オキソデヒドロアビエチン酸等のデヒドロアビ
エチン酸誘導体は、香料や、医薬品等の中間体として極
めて有用である。
Dehydroabietic acid is obtained in large quantities from natural pine resin. Dehydroabietic acid is a substance industrially useful as a sizing agent for papermaking and the like, but it is expected to be converted into a drug having a well-established structure and a higher added value. That is, 7-oxodehydroabietic acid obtained from dehydroabietic acid, 7
Dehydroabietic acid derivatives such as -hydroxydehydroabietic acid and 15-hydroxy-7-oxodehydroabietic acid are extremely useful as perfumes and intermediates for pharmaceuticals and the like.

【0003】本発明者らは先に、植物培養細胞であるム
レスズメ培養細胞を用いて、環状オレフィンから、香
料、医薬品及び農薬等の中間体に用いられる不飽和ケト
ン及びエポキシ化アルコール等の有用物の製造方法を提
案した(特開2001−252089)。ところで前記
のとおり、天然の松脂から多量に得られるデヒドロアビ
エチン酸は、構造が確立されていてさらに付加価値の高
い医薬品等への変換が期待され、特にデヒドロアビエチ
ン酸から得られる7−オキソデヒドロアビエチン酸、7
−ヒドロキシデヒドロアビエチン酸及び15−ヒドロキ
シ−7−オキソデヒドロアビエチン酸等のデヒドロアビ
エチン酸誘導体は、香料や、医薬品等の中間体として極
めて有用である。
The inventors of the present invention have previously described useful products such as unsaturated ketones and epoxidized alcohols, which are used as intermediates for fragrances, pharmaceuticals, agricultural chemicals, etc., from cyclic olefins, using cultured cells of Muresume which are cultured cells of plants. Has been proposed (Japanese Unexamined Patent Publication No. 2001-252089). By the way, as described above, dehydroabietic acid, which is obtained in large amounts from natural pine resin, is expected to be converted into a drug having a well-established structure and higher added value, and 7-oxodehydroabieticin obtained from dehydroabietic acid in particular Acid, 7
Dehydroabietic acid derivatives such as -hydroxydehydroabietic acid and 15-hydroxy-7-oxodehydroabietic acid are extremely useful as perfumes and intermediates for pharmaceuticals and the like.

【0004】[0004]

【発明が解決しようとする課題】そこで本発明の課題
は、デヒドロアビエチン酸からさらに付加価値の高いデ
ヒドロアビエチン酸誘導体を提供することである。つま
り本発明の課題は、デヒドロアビエチン酸を出発原料
に、従来のようにアルカリ金属、アルカリ土類金属、遷
移金属を含む重金属系の触媒を用いずに、しかも、常
温、常圧下の水溶媒中の穏和な反応条件下で、香料、医
薬品等の中間原料として極めて有用な7−オキソデヒド
ロアビエチン酸、7−ヒドロキシデヒドロアビエチン酸
及び15−ヒドロキシ−7−オキソデヒドロアビエチン
酸等のデヒドロアビエチン酸誘導体を得る製造方法を提
供することである。
Therefore, an object of the present invention is to provide a dehydroabietic acid derivative having a higher added value from dehydroabietic acid. That is, the object of the present invention is to use dehydroabietic acid as a starting material, without using a conventional heavy metal catalyst containing an alkali metal, an alkaline earth metal, or a transition metal, and at room temperature under normal pressure in a water solvent. Under mild reaction conditions of 7-oxodehydroabietic acid, 7-hydroxydehydroabietic acid and 15-hydroxy-7-oxodehydroabietic acid, which are extremely useful as intermediate materials for perfumes and pharmaceuticals, It is to provide a manufacturing method to obtain.

【0005】本発明者らは種々検討の結果、生体触媒で
あるムレスズメ培養細胞を用いることにより、重金属酸
化剤を用いることなく、省エネルギー下で、環境に優し
い方法でデヒドロアビエチン酸の酸化を行い得ることを
見出した。
As a result of various investigations, the present inventors have found that the use of a biocatalyst, the cultured cell of Astragalus membranaceus, makes it possible to oxidize dehydroabietic acid in an energy-saving and environmentally friendly manner without using a heavy metal oxidizing agent. I found that.

【0006】[0006]

【課題を解決するための手段】そこで本発明は、ムレス
ズメ培養細胞を用いて、デヒドロアビエチン酸から7−
オキソデヒドロアビエチン酸、7−ヒドロキシデヒドロ
アビエチン酸及び15−ヒドロキシ−7−オキソデヒド
ロアビエチン酸からなる群から選ばれる少なくとも1種
のデヒドロアビエチン酸誘導体を製造することを特徴と
するデヒドロアビエチン酸誘導体の製造方法である。
[Means for Solving the Problems] Therefore, according to the present invention, by using cultured cells of Japanese aureus, 7-
Production of dehydroabietic acid derivative, characterized in that at least one dehydroabietic acid derivative selected from the group consisting of oxodehydroabietic acid, 7-hydroxydehydroabietic acid and 15-hydroxy-7-oxodehydroabietic acid is produced. Is the way.

【0007】[0007]

【発明の実施の形態】以下に、本発明による実施形態に
ついて説明する。本発明によれば、デヒドロアビエチン
酸(1)を原料として、ムレスズメ培養細胞を生体触媒
とし、MS培養液中で培養反応させて、従来法とは異な
り、常温・常圧で、香料、医薬品等の中間原料として極
めて有用な7−オキソデヒドロアビエチン酸(2)、7
−ヒドロキシデヒドロアビエチン酸(3)及び15−ヒ
ドロキシ−7−オキソデヒドロアビエチン酸(4)等の
デヒドロアビエチン酸誘導体を得ることができる。反応
は下記の反応式に従って行われる。
BEST MODE FOR CARRYING OUT THE INVENTION Embodiments of the present invention will be described below. According to the present invention, dehydroabietic acid (1) is used as a raw material, and cultured cells of wolves are used as a biocatalyst to carry out a culture reaction in an MS culture solution. 7-oxodehydroabietic acid (2), 7 which is extremely useful as an intermediate raw material of
Dehydroabietic acid derivatives such as -hydroxydehydroabietic acid (3) and 15-hydroxy-7-oxodehydroabietic acid (4) can be obtained. The reaction is performed according to the following reaction formula.

【0008】[0008]

【化1】 [Chemical 1]

【0009】原料のデヒドロアビエチン酸は、天然の松
脂から多量に得ることができる。MS培養液中での培養
反応は、15〜30℃の温度範囲、より好ましくは20
〜25℃の温度範囲で、培養期間を5〜16日間、より
好ましくは10〜14日間として行う。
The raw material dehydroabietic acid can be obtained in large amounts from natural pine resin. The culture reaction in the MS culture medium is in the temperature range of 15 to 30 ° C., more preferably 20.
It is carried out at a temperature range of -25 ° C for a culture period of 5 to 16 days, more preferably 10 to 14 days.

【0010】またこの培養反応は、重量基準で生体触媒
100重量部に対して原料のデヒドロアビエチン酸を1
〜20重量部の範囲で添加し、静置下又は攪拌下で行う
が、攪拌下で行う方がより好ましい。
In this culture reaction, 1 part of dehydroabietic acid as a raw material was added to 100 parts by weight of the biocatalyst on a weight basis.
It is added in the range of 20 to 20 parts by weight, and the addition is carried out under standing or with stirring, but it is more preferable to carry out with stirring.

【0011】本発明で用いる植物培養細胞であるムレス
ズメ培養細胞は、生体の組織または器官の一部を生体か
ら取り出し、適当な培養培地で生育させたもの(カル
ス)であって、植物ムレスズメ(Caragana chamlagu)
の葉や茎などから誘導し、MS固体培地上で増殖させて
調製することができる。
[0011] The Murrezu cultivated cells, which are the plant cultured cells used in the present invention, are obtained by removing a part of the tissue or organ of the living body from the living body and growing it in a suitable culture medium (callus). chamlagu)
It can be prepared by inducing from leaves or stems and growing on MS solid medium.

【0012】[0012]

【実施例】以下に本発明の実施例を示すが、本発明はこ
れらに限定されるものではない。
EXAMPLES Examples of the present invention will be shown below, but the present invention is not limited thereto.

【0013】実施例1 MS液体培地100mlにムレスズメ培養細胞4gを加
えて2日間、前培養を行った。次いで、この培地に原料
のデヒドロアビエチン酸60mgを添加し、温度25℃
で、緩やかな攪拌下、暗所で21日間振とう培養を行っ
た。反応終了後、培養細胞を濾過分離し、得られた濾液
にエーテルを加えて溶媒抽出を行った。得られた抽出液
をジアゾメタンでメチル化後、無水硫酸ナトリウムを加
えて脱水し、次いで溶媒を留去した。得られた粗反応生
成物を、シリカゲルカラムクロマトグラフィーにより分
離した。スペクトルデータより生成物の構造を確認し、
物質同定を行った。
Example 1 To 100 ml of MS liquid medium, 4 g of Muresume culture cells were added and precultured for 2 days. Next, 60 mg of dehydroabietic acid as a raw material was added to this medium, and the temperature was 25 ° C.
Then, shaking culture was carried out for 21 days in the dark with gentle stirring. After the reaction was completed, the cultured cells were separated by filtration, ether was added to the obtained filtrate, and solvent extraction was performed. The obtained extract was methylated with diazomethane, dehydrated by adding anhydrous sodium sulfate, and then the solvent was distilled off. The obtained crude reaction product was separated by silica gel column chromatography. Confirm the structure of the product from the spectral data,
The substance was identified.

【0014】物質同定の結果は下記のとおりであった。 <メチル-7-オキソデヒドロアビエテート>m/z;32
8.2035(C21283),IR;1716cm-1(C=O),1
674cm-1(C=O),1604cm-1(C=C),1H−N
MR;1.24(3H,CH3),1.26(6H, CH3),1.34(3
H,CH3),3.65( 3H,CH3),13C−NMR;177.84
(COOCH3),198.59(C=O) <メチル-7β-ヒドロキシデヒドロアビエテート>m/
z;330.2196(C21303),IR;3348(OH),1712c
-1(C=O),1600cm-1(C=C),1H−NMR;1.2
4(3H,CH3),1.28(3H, CH3),1.56(6H,C
3),3.66(3H,CH 3),4.86(1H,CH-OH),13C−NM
R;70.7(CH-OH),178.7(COOCH3) <メチル-15-ヒドロキシ-7-オキソデヒドロアビエテー
ト>m/z;344.1983(C21284),IR;3350cm
-1(OH),1720cm-1(C=O),1664cm-1(C=O),
1620cm-1(C=C),1H−NMR;1.25(3H,C
3),1.27(3H,CH3),1.60(3H,CH3),1.61(3
H,CH3),3.65(3H,CH3),13C−NMR;83.6(C-O
H),177.8(COOCH3),198.3(C=O)
The results of substance identification were as follows. <Methyl-7-oxodehydroabietate> m / z; 32
8.2035 (Ctwenty oneH28O3), IR; 1716cm-1(C = O), 1
674 cm-1(C = O), 1604cm-1(C = C), 1H-N
MR; 1.24 (3H, CH3), 1.26 (6H, CH3), 1.34 (3
H, CH3), 3.65 (3H, CH3), 13 C-NMR; 177.84
(COOCH3), 198.59 (C = O) <Methyl-7β-hydroxydehydroabietate> m /
z; 330.2196 (Ctwenty oneH30O3), IR; 3348 (OH), 1712c
m-1(C = O), 1600cm-1(C = C), 1H-NMR; 1.2
4 (3H, CH3), 1.28 (3H, CH3), 1.56 (6H, C
H3), 3.66 (3H, CH 3), 4.86 (1H, CH-OH), 13C-NM
R; 70.7 (CH-OH), 178.7 (COOCH3) <Methyl-15-hydroxy-7-oxodehydroabiete
G> m / z; 344.1983 (Ctwenty oneH28OFour), IR; 3350 cm
-1(OH), 1720cm-1(C = O), 1664cm-1(C = O),
1620 cm-1(C = C), 1H-NMR; 1.25 (3H, C
H3), 1.27 (3H, CH3), 1.60 (3H, CH3), 1.61 (3
H, CH3), 3.65 (3H, CH3), 13 C-NMR; 83.6 (C-O
H), 177.8 (COOCH3), 198.3 (C = O)

【0015】製品収量 7−オキソデヒドロアビエチン酸(22%)及び7−ヒ
ドロキシデヒドロアビエチン酸(13%)及び15−ヒ
ドロキシ−7−オキソデヒドロアビエチン酸(13%)
が得られた。
Product yield 7-oxodehydroabietic acid (22%) and 7-hydroxydehydroabietic acid (13%) and 15-hydroxy-7-oxodehydroabietic acid (13%)
was gotten.

───────────────────────────────────────────────────── フロントページの続き Fターム(参考) 4B064 AE41 BA04 BH02 BH04 BH05 BH07 CA11 CB11 CB12 CC03 CD07 DA01 DA16    ─────────────────────────────────────────────────── ─── Continued front page    F-term (reference) 4B064 AE41 BA04 BH02 BH04 BH05                       BH07 CA11 CB11 CB12 CC03                       CD07 DA01 DA16

Claims (3)

【特許請求の範囲】[Claims] 【請求項1】 植物培養細胞であるムレスズメ培養細胞
を用いて、デヒドロアビエチン酸から7−オキソデヒド
ロアビエチン酸、7−ヒドロキシデヒドロアビエチン酸
及び15−ヒドロキシ−7−オキソデヒドロアビエチン
酸からなる群から選ばれる少なくとも1種のデヒドロア
ビエチン酸誘導体を製造することを特徴とするデヒドロ
アビエチン酸誘導体の製造方法。
1. Using a cultured cell of Muresume, which is a plant cultured cell, selected from the group consisting of dehydroabietic acid to 7-oxodehydroabietic acid, 7-hydroxydehydroabietic acid and 15-hydroxy-7-oxodehydroabietic acid. A method for producing a dehydroabietic acid derivative, which comprises producing at least one dehydroabietic acid derivative as described above.
【請求項2】 前記デヒドロアビエチン酸誘導体が7−
オキソデヒドロアビエチン酸及び7−ヒドロキシデヒド
ロアビエチン酸の混合物であることを特徴とする請求項
1に記載のデヒドロアビエチン酸誘導体の製造方法。
2. The dehydroabietic acid derivative is 7-
The method for producing a dehydroabietic acid derivative according to claim 1, which is a mixture of oxodehydroabietic acid and 7-hydroxydehydroabietic acid.
【請求項3】 デヒドロアビエチン酸の15位を水酸化
して、15−ヒドロキシ−7−オキソデヒドロアビエチ
ン酸を得ることを特徴とする請求項1又は2に記載のデ
ヒドロアビエチン酸誘導体の製造方法。
3. The method for producing a dehydroabietic acid derivative according to claim 1, wherein 15-hydroxy-7-oxodehydroabietic acid is obtained by hydroxylating the 15-position of dehydroabietic acid.
JP2002061259A 2002-03-07 2002-03-07 Method for producing dehydroabietic acid derivative Pending JP2003259891A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2002061259A JP2003259891A (en) 2002-03-07 2002-03-07 Method for producing dehydroabietic acid derivative

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2002061259A JP2003259891A (en) 2002-03-07 2002-03-07 Method for producing dehydroabietic acid derivative

Publications (1)

Publication Number Publication Date
JP2003259891A true JP2003259891A (en) 2003-09-16

Family

ID=28670253

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2002061259A Pending JP2003259891A (en) 2002-03-07 2002-03-07 Method for producing dehydroabietic acid derivative

Country Status (1)

Country Link
JP (1) JP2003259891A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104151208A (en) * 2014-08-07 2014-11-19 广西众昌树脂有限公司 Preparation method for sulfonated dehydroabietic acid

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104151208A (en) * 2014-08-07 2014-11-19 广西众昌树脂有限公司 Preparation method for sulfonated dehydroabietic acid

Similar Documents

Publication Publication Date Title
Hoffmann et al. Stereoselective synthesis of alcohols, XXXI: Stereoselective C C bond formation using chiral Z‐pentenylboronates
FR2473519A1 (en) TERPENOIDS CONTAINING TWO FUNCTIONAL GROUPS, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION
DE4034218A1 (en) METHOD FOR PRODUCING CAREBASTIN
JPS6340192B2 (en)
FR2479809A1 (en) CHOLESTEROL BIOSYNTHESIS INHIBITOR COMPOUNDS, PROCESS FOR PREPARING THEM AND THERAPEUTIC APPLICATION THEREOF
JPH0826027B2 (en) Ginkgolide derivatives and their preparation
JP2003259891A (en) Method for producing dehydroabietic acid derivative
JPH06256278A (en) Optically active alpha-carbamoylalkanoic acid derivative and its production
CA1133929A (en) Process for the preparation of pyrethrins and analogues thereof and insecticidal compositions containing the same
KR102423638B1 (en) Method For Making Astaxanthin Monoester
DE3237632A1 (en) Process for the preparation of long-chain linear wax alcohols
CN110105311B (en) Synthetic method of sex pheromone intermediate of fall webworm
JPS6261587A (en) Production of optically active (r)-hydroxymandelic acid ester intermediate
CH449006A (en) Process for the preparation of fusidic acid and dihydrofusidic acid derivatives
JP3092865B2 (en) Method for producing optically active [3] (1,1 &#39;) ferrocenophanes
JP2609922B2 (en) 2&#39;-Ketopantothenic acid ester
JP2926254B2 (en) Method for producing natural jasminic acid
DE3237620C2 (en)
JPH04346963A (en) New chlorinated compound and its production and production of optically active lactone using the same
JPS60231629A (en) 10-acetoxy-4,8-dimethyldeca-3,8-dienoic acid and 10-hydroxy-4,8-dimethyldeca-3,8-dienoic acid
JPS61176546A (en) Fluorine-containing carbonyl compound and production thereof
JP3227020B2 (en) Ketals and their production
DE3727411A1 (en) Process for the preparation of 2-indolinecarboxylic acid
DE2242792A1 (en) METHOD OF MANUFACTURING PROSTAGLANDINES
DE1470329A1 (en) Process for the preparation of organic compounds